Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 2	2026-08-28		NCT06648889

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Goethe University	23
Sanofi	254

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Charité Berlin, Campus Benjamin Franklin, Department of Hematology, Oncology and Tumorimmunologyt Hämatologie	Berlin	Germany	1
Gesundheit Nord Klinikverbund Bremen gGmbH, Klinikum Bremen-Mitte, Med. Klinik I	Bremen	Germany	1
Goethe University Hospital Frankfurt, Department of Medicine, Hematology and Oncology	Frankfurt am Main	Germany	1
Klinikum Carl Gustav Carus Dresden, Medizinische Klinik und Poliklinik I	Dresden	Germany	1
Klinikum Oldenburg AöR, Universitätsklinik für Innere Medizin - Onkologie und Hämatologie	Oldenburg	Germany	1
Robert-Bosch-Krankenhaus; Abteilung für Hämatologie, Onkologie und Palliativmedizin	Stuttgart	Germany	1
University Hospital Augsburg, II. Medizinischen Klinik, Hämatologie, internistische Onkologie und Hämostaseologie	Augsburg	Germany	1
University Hospital Düsseldorf, Department of Hematology, Oncology and Clinical Immunology	Düsseldorf	Germany	1
University Hospital Erlangen AöR, Department of Medicine 5	Erlangen	Germany	1
University Hospital Hamburg-Eppendorf, Department of Medicine II	Hamburg	Germany	1
University Hospital Heidelberg, Department V, Hematology, Oncology and Rheumatology	Heidelberg	Germany	1
University Hospital Leipzig; Klinik für Hämatologie, Zelltherapie, Hämostaseologie und Infektiologie, Bereich Hämatologie und Zelltherapie	Leipzig	Germany	1
University Hospital München-Großhadern, Medizinische Klinik und Poliklinik III	München	Germany	1
University Hospital Münster, Medizinische Klinik A / KMT-Zentrum	Münster	Germany	1
University Hospital Schleswig-Holstein, Campus Kiel, Medical Department II	Kiel	Germany	1